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Abstract 
Over the past ten years there has been an increasing interest in the conjugation of exogenous compounds to the 
surface of M13 bacteriophage. M13 offers a convenient scaffold for the development of nano-assemblies with useful 
functions, such as highly specific drug delivery and pathogen detection. However, the progress of these technologies 
has been hindered by the limited efficiency of conjugation to the bacteriophage. Here we generate a mutant version 
of M13 with an additional lysine residue expressed on the outer surface of the M13 major coat protein, pVIII. We 
show that this mutation is accommodated by the bacteriophage and that up to a further 520 exogenous groups can be 
attached to the bacteriophage surface via amine-directed conjugation. These results could aid the development of 
high payload drug delivery nano-assemblies and pathogen detection systems with increased sensitivity. 
 
M13 bacteriophage (M13) is a filamentous, non-lytic coliphage that was first isolated around fifty years ago.1 M13 
has a simple and highly efficient genome with only eleven genes, two of which overlap entirely with neighboring 
genes whilst producing discrete gene products.2-5 The coat of M13 comprises ~2700 copies of the major coat protein, 
pVIII and five copies each of the minor coat proteins pIII, pVI, pVII and pIX. The pVIII coat is arranged as stacked 
pentameric rings, giving M13 a cylindrical shape with a high aspect ratio of ~6 nm by ~1000 nm.6-8 The 50 amino 
acid major coat protein, pVIII, is almost entirely alpha-helical and is arranged with its carboxy-terminus associated 
with the single-stranded circular DNA at the core of the virion, and its amino-terminus surface-exposed.9 
 
Functional groups within the pVIII coat of M13 can be targeted for the chemical conjugation of exogenous 
molecules to the bacteriophage to create nano-assemblies with non-biological functions.10 For amine-directed 
conjugation, it is the amine group of the amino-terminus of pVIII, and to a lesser extent the ε-amine group of the 
lysine residue at position eight that are targeted for conjugation of exogenous compounds.11 Conjugated species 
include antibiotics,12 anti-cancer drugs,13 chromophores,11,14,15 NMR contrast agents,16 antibodies and aptamers. 
However each of these studies have identified a common issue with using M13. In all cases the level of conjugation 
to the virion surface limited the performance of the product. This limitation was starkly demonstrated in the use of 
M13 to target folate receptors on the surface of cancer cells by conjugating folate to the surface of M13. In this case 
multivalency was said to play a role in strengthening the bond between the conjugated molecules and their target,11 
meaning that increasing conjugation of folate to the surface of the M13 would have increased the effectiveness of 
the reagent. We have observed the same limitation in our laboratory where we aim to use dye-labeled M13 as the 
basis of a diagnostics test.17 Our experience is that the number of dye molecules on the bacteriophage surface is 
directly related to the eventual sensitivity of the assay. We have studied the conjugation of wild type M13 using the 
model dye 4-chloro-7-nitrobenzofurazan (NBD-Cl). NBD-Cl is a relatively small dye meaning that steric effects on 
conjugation should be kept to a minimum. Our studies have shown that conjugation efficiencies of approximately 
1200 dye molecules per virion are the maximum that can be achieved. This result agrees with previous studies on 
this subject.11,15 We suspect that this upper limit indicates that despite its small size NBD-Cl conjugation is still 
limited by steric hindrance from other side chains that surround the conjugation site.  
 
As smaller dyes are not readily available one solution to this problem would be to introduce additional conjugation 
sites onto the surface. Presented here is a systematic study of the effect of substituting additional lysine residues into 
a variety of positions on the solvent-exposed face of pVIII. For each mutant the effect on viral viability is assessed 
and if the mutation is non-lethal then the conjugation efficiency is also quantified. Using this approach we were able 
to introduce an additional lysine residue – and thereby an additional ~2700 amine groups to the overall surface of 
M13 – to the amino-terminal region of bacteriophage M13 major coat protein pVIII (Figure 1), imparting an 
increased capacity for amine-directed conjugation of exogenous compounds. To prove the utility of this new mutant 
form of M13, conjugation of a range of dyes (including NBD-Cl, Cyanine3 (Cy3), Tetramethylrhodamine 
iosthiocyanate (TRITC) and Cyanine5 (Cy5)) were tested for their conjugation efficiency to bacteriophage.  These 
data showed that in all cases dye conjugation efficiency was improved in the mutant bacteriophage expressing an 
additional Lys residues compared to the wild type, with up to 520 additional exogenous chromophores being bound. 
 
 
Figure 1. Scheme for the generation of M13 mutants displaying additional lysine residues. Schematic of 
bacteriophage M13 procoat. Positively charged residues labeled with ‘+’, and negatively charged residues labeled 
with ‘-’. Nucleotide and amino acid sequences of the amino-terminal region of mature pVIII, both wild type (wt) 
and mutant. Alterations to nucleotide sequence displayed in red. 
 
During the M13 bacteriophage replication cycle, amino acid residues +1 to +20 of M13 procoat (Figure 1) are 
translocated across the Escherichia coli (E. coli) inner membrane from the cytoplasm to the periplasm, allowing 
proteolytic cleavage to occur, producing mature pVIII and allowing the assembly of the M13 virion. Of the 
mutations attempted during the production of mutant M13, we observed that all those that caused a net positive 
change in the charge of pVIII were non-viable (Table 1). This is a significant issue as the conjugation systems often 
used rely on the presence of the positively charged amine on the side chain of lysine. The observation of this 
abolition of viability is consistent with the findings of Schuenemann et al. (1999),18 who showed that prior to the 
assembly of M13 inside its host, the proton motive force across the inner membrane of E. coli inhibits the 
translocation of positively charged residues from the cytoplasm to the periplasm, thus preventing completion of the 
M13 replicative cycle when additional positive charge is added to the amino terminal region of pVIII.   
+1	-1	-23	 +50	
++++	++					+	 -	-	-	-			+	
Signal peptide Mature pVIII 
		A			E				G				D			D				P			A				K				A			A	
GCTGAGGGTGACGATCCCGCAAAAGCGGCC	
A1K 			K				E				G				D			D			P			A				K		
							AAAGAGGGTGACGATCCCGCAAAA…	
E2K 			A			K				G			D				D			P			A				K		
							GCTAAAGGTGACGATCCCGCAAAA…	
G3K 			A			E				K				D			D				P			A				K		
							GCTGAGAAAGACGATCCCGCAAAA…	
D4K 			A			E					G			K			D				P			A				K		
							GCTGAGGGTAAAGATCCCGCAAAA…	
D5K 			A			E				G			D				K				P			A			K		
							GCTGAGGGTGACAAACCCGCAAAA…	
1	 10	
M13 
mutants 
wt M13 
  
Table 1. Effect of mutation on major coat protein charge and bacteriophage viability. 
Mutation ∆ chargea Viable? Y/Nb 
A1K +1 N 
E2K +2 N 
G3K +1 N 
D4K +2 N 
D5K +2 N 
A1KN12D 0 Y 
A1KG3E 0 N 
G3KN12D 0 Y 
G3KA1E 0 Y 
a Per pVIII monomer; b As determined by DNA sequencing 
 
Applying the findings of Schuenemann et al. (1999),18 the mutations that resulted in a change in charge of +1 per 
pVIII monomer (A1K and G3K) were repeated alongside a secondary mutation that would cancel out the addition of 
a positive charge by the addition of a negatively charged residue (asparagine at position 12 to aspartic acid, N12D). 
The two mutants resulting from this approach, A1KN12D and G3KN12D, were viable (Table 1). Conjugation 
experiments using NBD-Cl were carried out to examine whether the new mutant forms of M13 could be labeled 
with a higher number of exogenous groups than wild type. Unfortunately UV-vis spectroscopy showed that neither 
A1KN12D nor G3KN12D increased the level of conjugation despite the addition of an additional lysine residue. 
Examination of the structure of the M13 coat suggests strongly that introduction of a negatively charged aspartate 
group at position 12 (D12) could lead to the formation of a salt bridge between D12 and the Lys residue at position 
eight (K8), altering the orientation of K8.19 K8 contains one of the two solvent accessible amine groups in wild type 
M13 that are derivatized during conjugation reactions. It seems likely that if the introduction of an aspartate at 
position 12 is leading to an ion bridge then this will inhibit conjugation of K8, meaning that one conjugation site was 
added at positions one or three whilst another was effectively removed from position eight (Figure S1) leading to no 
improvement in conjugation efficiency. To overcome this issue two alternative mutations (at positions 1 or 3) were 
made in an attempt at balancing the charge of an introduced lysine while not forming a salt bridge with the wild type 
K8. Analysis of these mutants found that A1KG3E was non-viable however G3KA1E was found to be viable by plaque 
assay with sequencing showing that viability was not the result of genetic reversion (Table 1). To test the 
conjugation efficiency of G3KA1E compared to wild type M13, the two bacteriophage variants were separately 
combined with NBD-Cl before removing unreacted dye by size exclusion chromatography. UV-vis analysis was 
used to quantify the number of dye molecules bound to the surface of M13 as the two entities have clear and distinct 
absorbance spectra. M13 has a band at 269 nm with an extinction coefficient of 3.84 mg-1.cm-2,20 while NBD-Cl 
when bound to an amine group absorbs at 475 nm with an extinction coefficient of 18293 M-1.cm-1 (Figure S2). 
When the two reaction products were compared by UV-vis analysis, the peaks attributable to dye were more 
prominent in the sample that contained G3KA1E than wild type M13 (Figure 2 a), indicating that there was more dye 
bound to the mutant than the wild type. Quantification of the number of NBD groups bound to each type of 
bacteriophage indicated that there were 1201 ± 12 NBD groups per wild type virion (consistent with our findings 
that this was the upper limit of NBD-Cl conjugation to the wild type bacteriophage, Figure S3) and 1491 ± 20 NBD 
groups per G3KA1E virion, a significant increase (p < 0.0001) of 290 dye molecules per virion (Figure 2 a and e). 
When the experiment was repeated with Cy3 in place of NBD-Cl, the absorbance spectra of the dye when bound to 
the different bacteriophage variants did not match closely, indicating dye aggregation (Figure 2 b, solid lines), which 
in the case of H-aggregation causes hypochromicity, thus suggesting that the absorbance values did not represent the 
true concentration of the dye bound to the bacteriophage variants, making proper comparison of the conjugation 
efficiencies unreliable. To overcome this, the samples were measured again in the presence of Triton X-100 at a 
1/1000 (v/v) concentration to prevent dye aggregation. Analysis of the resulting spectra (Figure 2 b, dashed lines) 
revealed 1417 ± 28 Cy3 groups per wild type virion compared to 1937 ± 320 Cy3 groups per G3KA1E virion, a 
significant increase (p < 0.05) of 520 dye molecules per virion (Figure 2 e). When the conjugation was repeated with 
TRITC, UV-vis analysis revealed 359 ± 8 TRITC groups per wild type virion compared to 672 ± 65 TRITC groups 
per G3KA1E virion, a significant increase (p = 0.001) of 313 TRITC groups per virion (Figure 2 c and e). Finally, 
when the conjugation experiment was repeated with Cy5, as with Cy3, the spectra of the dye bound to the different 
bacteriophage samples did not match closely (Figure 2 d, solid lines), indicating dye aggregation, thus Triton X-100 
was added and the UV-vis measurements were repeated. Analysis of the resulting spectra (Figure 2 d, dashed lines) 
revealed 614 ± 160 Cy5 groups per wild type virion compared to 1067 ± 24 Cy5 groups per G3KA1E virion, a 
significant increase (p = 0.008) of 453 Cy5 groups per virion (Figure 2 d and e). Furthermore, gel electrophoresis in 
denaturing conditions confirmed dye conjugation to bacteriophage (Figure S4). 
 
 
Figure 2. Conjugation of exogenous chromophores to M13 variants (n=3, error bars represent one standard 
deviation). (a) Absorbance spectra of wild type (wt) and G3KA1E M13 bacteriophage following conjugation to (a) 
NBD-Cl, (b) Cy3, (c) TRITC and (d) Cy5. (e) Conjugation efficiencies of wt and G3KA1E M13 bacteriophage to 
dyes indicated in the figure. Where Triton X-100 was used, the values used to calculate conjugation efficiency were 
those from the spectra measured in the presence of Triton X-100. 
 
We have shown that the introduction of additional lysine residues into the coat of M13 adversely affects viral 
propagation. This results from an increase in positive charge on pVIII that interferes with the viral assembly process. 
This observation is consistent with results obtained by: 1) Merzlyak and Lee (2009),20 who – when attempting to 
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introduce up to six Lys residues to the amino-terminal region of pVIII in a partial library approach - found that they 
were able to introduce only one additional Lys residue and that the attempted introduction of 2-6 Lys residues only 
yielded plaques due to deletions or wild type DNA; 2) Schuenemann et al. (1999),18 who observed that the proton 
motive force across the inner membrane of E. coli prevents the translocation of M13 immature pVIII when 
positively charged residues are added via mutagenesis, thus halting M13 replication; and 3) Kuzmicheva et al. 
(2008),22 who observed an under-representation of positively charged residues in pVIII phage display, suggesting 
that there is a disadvantage to the expression of such residues. Applying these observations, we designed rescue 
mutations in an effort to allow the expression of an additional Lys residue in pVIII. While the introduction of a 
second, charge-neutralising mutation alongside A1K (N12D) and G3K (N12D or A1E) allowed the propagation of 
these mutations (albeit with a reduced titer compared to wild type, Figure S5), which were non-viable when 
introduced to a wild type background, not all rescue mutations allowed propagation (A1KG3E), demonstrating that 
this approach is not always effective, suggesting that there are determinants of M13 viability that are as yet not 
understood. Following the generation of the mutants, their conjugation efficiencies were determined by binding to 
NBD-Cl, Cy3, TRITC and Cy5. Of the three mutants generated, only G3KA1E showed an increase in conjugation 
efficiency compared to wild type M13. 
 
We have shown that the addition of lysine residues to the coat of M13 is not a trivial process and that certain rules 
need to be followed to ensure that the virus is viable and that conjugations sites are available. By following these 
rules we have developed a mutant strain of M13 that is viable and has increased conjugation efficiency above wild 
type. As a number of studies have cited that their progress was limited by conjugation efficiency, we propose that 
this mutant form of M13 could find use in the development of new – or the improvement of existing – technologies 
that rely on the conjugation of exogenous compounds to the outer surface of M13 bacteriophage. 
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